PlainRecalls
ModerateClass IICompleted

FDA Devices recall · Reported August 22, 2018

Nokia BPM+ Wireless Blood Pressure Monitor Product System, measurement, blood-pressure, non-invasive

Device could not meet the requirements for systolic pressure

Recall #
Z-2829-2018
Affected scope
Total 44,000 units (15,139 US/ 28,861 OUS)
Initiated
June 11, 2018
Compiled from official public sources by the editorial team.
Verify with FDA Devices →
View my saved recalls

Withings Sas recalled Nokia BPM+ Wireless Blood Pressure Monitor Product System, measurement, blood-pressur… - a moderate-severity action.

Nokia BPM+ Wireless Blood Pressure Monitor Product System, measurement, blood-pressur… was recalled by Withings Sas in August 22, 2018. Reason: Device could not meet the requirements for systolic pressure. Check the official notice for the remedy. Verify recall #Z-2829-2018 with the FDA Devices before acting.

The recall

Withings Sas issued this moderate-severity FDA Devices recall-Device could not meet the requirements for systolic pressure.

Moderate
severity level
Class II
classification
August 22, 2018
reported

Sourced from official FDA Devices enforcement records. Verify recall #Z-2829-2018 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Devices action (record #Z-2829-2018) was formally reported on August 22, 2018, with the manufacturer initiating the action on June 11, 2018. It is classified under Moderate severity (Class II), with a current status of Completed. Withings Sas is listed as the recalling firm, operating out of Issy les Moulineaux. Federal records list the affected scope as Total 44,000 units (15,139 US/ 28,861 OUS).

The documented reason for this recall is: Device could not meet the requirements for systolic pressure Distribution data in the federal record shows the product reached: US Nationwide Distribution. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Medical Devices recalls over time

Where this recall sits in its category - 40,422 medical devices recalls on record

-1,00001,0002,0003,0004,0005,000 20052008201120142017202020232026 1,256
Severity2487872426High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Severity

Moderate

Affected scope

Total 44,000 units (15,139 US/ 28,861 OUS)

Related Recalls

6

0 from same agency

Product description

Nokia BPM+ Wireless Blood Pressure Monitor Product System, measurement, blood-pressure, non-invasive

Reason for recall

Device could not meet the requirements for systolic pressure

Recall Profile

Structured summary of the FDA Devices recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Moderate (Class II)
Status Completed
Recall number Z-2829-2018
Date reported August 22, 2018
Date initiated June 11, 2018
Recalling firm Withings Sas
Firm location Issy les Moulineaux
Affected scope Total 44,000 units (15,139 US/ 28,861 OUS)
Distribution US Nationwide Distribution

Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (Z-2829-2018) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Devices before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
Nokia BPM+ Wireless Blood Pressure Monitor Product System, measurement, blood-pressure, non-invasive. Recalled by Withings Sas. Units affected: Total 44,000 units (15,139 US/ 28,861 OUS).
Why was this product recalled?
Device could not meet the requirements for systolic pressure
Which agency issued this recall?
This recall was issued by the FDA Devices on August 22, 2018. Severity: Moderate. Recall number: Z-2829-2018.
Where was the recalled product distributed?
Distribution: US Nationwide Distribution.
How do I check if my product is affected by a recall?
Check the product description and recall number (Z-2829-2018) against your product. Visit the official FDA Devices website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nearby Recalls in This Category

Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →

Browse all Medical Devices recalls →

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported August 22, 2018. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.